Document is current
Any future updates will be listed below
-
Authors
Zhou, Chao
Liu, Yuqing
Liu, Hongyu
Lu, Jun https://orcid.org/0000-0002-7343-9706
Zhang, Bo
Zhu, Liang https://orcid.org/0000-0002-9383-392X
Wang, Shuyuan
Lei, Huimin
Han, Baohui https://orcid.org/0000-0002-3950-3030
-
Funding
Funding for this research was provided by:
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (8227103163)
National multi-disciplinary treatment project for major disease
- License Information
-
More Information
Article History
Received: 21 February 2025
Revised: 24 July 2025
Accepted: 20 August 2025
First Online: 30 August 2025
Competing interests
: The authors declare no competing interests.
: Animal studies were conducted with the approval of the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University School of Medicine (JUMC2023-132). The study involving TMA was approved by the Life Sciences Ethics Committee of Changsha Yaxiang Biotechnology Co., LTD. The Ethics report is available online at yxswll.ccrl.cn using the query code 17ZK2S93GK12QX. Informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.
